Sirtex stuns market with $1.6bn US takeover offer

SYDNEY: Cancer drug developer Sirtex last night surprised investors with an agreed 1.58 billion takeover

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In